Three-year treatment outcomes of water vapor thermal therapy (Rezum System) compared to doxazosin, finasteride and combination drug therapy for men with benign prostatic hyperplasia: Cohort data from the Medical Therapy of Prostatic Symptoms (MTOPS) Trial
The Journal of Urology Mar 06, 2018
Gupta N, et al. - In cohorts from the Medical Therapy of Prostatic Symptoms (MTOPS) study, a one-time water vapor thermal therapy procedure was compared with the daily medical therapy by the evaluation of long-term outcomes of treatment for lower urinary tract symptoms due to benign prostatic hyperplasia. Efficacious and durable improvements in symptom scores with lower observed clinical progression rates were provided by a single water vapor thermal therapy procedure when compared with daily, long-term use of pharmaceutical agents.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries